News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
39,191 Results
Type
Article (2504)
Company Profile (40)
Press Release (36643)
Multimedia
Podcasts (7)
Webinars (2)
Section
Business (14165)
Career Advice (78)
Deals (2088)
Drug Delivery (9)
Drug Development (4124)
Employer Resources (10)
FDA (434)
Job Trends (774)
News (20206)
Policy (1053)
Tag
Academia (144)
Allergies (7)
Alliances (3490)
ALS (4)
Alzheimer's disease (51)
Antibody-drug conjugate (ADC) (20)
Approvals (433)
Artificial intelligence (18)
Autoimmune disease (3)
Automation (1)
Bankruptcy (12)
Best Places to Work (475)
BIOSECURE Act (2)
Biosimilars (14)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (6)
Breast cancer (29)
Cancer (235)
Cardiovascular disease (6)
Career advice (64)
Career pathing (1)
CAR-T (22)
Cell therapy (61)
Cervical cancer (2)
Clinical research (3304)
Collaboration (142)
Company closure (2)
Compensation (76)
COVID-19 (181)
CRISPR (10)
C-suite (58)
Cystic fibrosis (5)
Data (243)
Denatured (6)
Depression (8)
Diabetes (15)
Diagnostics (474)
Digital health (1)
Diversity (1)
Diversity, equity & inclusion (1)
Drug discovery (19)
Drug pricing (8)
Duchenne muscular dystrophy (23)
Earnings (4398)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6225)
Executive appointments (119)
FDA (526)
Funding (109)
Gene editing (22)
Gene therapy (31)
GLP-1 (61)
Government (152)
Guidances (21)
Healthcare (707)
Huntington's disease (4)
IgA nephropathy (9)
Immunology and inflammation (27)
Immuno-oncology (4)
Indications (3)
Infectious disease (189)
Inflammatory bowel disease (14)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (16)
Interviews (7)
IPO (1000)
IRA (7)
Job creations (292)
Job search strategy (62)
Kidney cancer (6)
Labor market (9)
Layoffs (46)
Leadership (1)
Legal (213)
Liver cancer (6)
Longevity (1)
Lung cancer (23)
Lymphoma (8)
Management (4)
Manufacturing (30)
MASH (7)
Medical device (310)
Medtech (310)
Mergers & acquisitions (1184)
Metabolic disorders (48)
Multiple sclerosis (16)
Neurodegenerative disease (19)
Neuropsychiatric disorders (5)
Neuroscience (127)
NextGen: Class of 2025 (352)
Non-profit (154)
Now hiring (8)
Obesity (22)
Opinion (16)
Ovarian cancer (16)
Pain (16)
Pancreatic cancer (14)
Parkinson's disease (7)
Partnered (2)
Patents (39)
Patient recruitment (12)
Peanut (1)
People (5761)
Pharmaceutical (5)
Phase I (1418)
Phase II (1648)
Phase III (880)
Pipeline (186)
Policy (14)
Postmarket research (30)
Preclinical (624)
Press Release (2)
Prostate cancer (6)
Psychedelics (2)
Radiopharmaceuticals (13)
Rare diseases (38)
Real estate (422)
Recruiting (5)
Regulatory (844)
Reports (7)
Research institute (144)
Resumes & cover letters (9)
RNA editing (5)
Schizophrenia (15)
Series A (31)
Series B (12)
Service/supplier (2)
Sickle cell disease (2)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (495)
Stomach cancer (2)
Supply chain (4)
The Weekly (1)
Vaccines (40)
Venture capital (11)
Weight loss (15)
Women's health (3)
Worklife (1)
Date
Last 7 days (48)
Last 30 days (164)
Last 365 days (2448)
2025 (1738)
2024 (2611)
2023 (2858)
2022 (3755)
2021 (4052)
2020 (3471)
2019 (2061)
2018 (1554)
2017 (1798)
2016 (1625)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (44)
Alabama (2)
Arizona (16)
Asia (1905)
Australia (302)
California (1255)
Canada (191)
China (56)
Colorado (31)
Connecticut (12)
Delaware (4)
Europe (3924)
Florida (52)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (17)
India (1)
Indiana (40)
Japan (12)
Kansas (12)
Kentucky (1)
Maryland (33)
Massachusetts (435)
Michigan (11)
Minnesota (19)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (102)
New York (63)
North Carolina (109)
Northern California (570)
Ohio (32)
Oklahoma (2)
Oregon (5)
Pennsylvania (78)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (520)
Tennessee (3)
Texas (113)
United States (2491)
Utah (3)
Virginia (7)
Washington D.C. (1)
Washington State (70)
West Virginia (1)
Wisconsin (8)
39,191 Results for "caladrius biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Collaboration
Eli Lilly Commits $856M in Biobucks to Gate Bioscience for New Class of Medicines
The collaboration focuses on ‘molecular gates,’ a class of molecules that the startup company Gate Bioscience says can stop pathogenic proteins from leaving the cell.
July 25, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Kuros Biosciences announces changes in the Board of Directors
September 4, 2025
·
3 min read
Deals
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius”) and Cend Therapeutics, Inc. (“Cend”) today announced that the proposed merger of the two companies has closed following the approval of Caladrius’ stockholders on September 13, 2022.
September 15, 2022
·
8 min read
Press Releases
Solid Biosciences to Participate at Upcoming September 2025 Investor Conferences
August 29, 2025
·
2 min read
Press Releases
Twist Bioscience Collaborates with Synthetic Design Lab
September 3, 2025
·
5 min read
Press Releases
Bright Minds Biosciences to Present at Upcoming Conferences
August 25, 2025
·
1 min read
Pharm Country
Caladrius Biosciences to Present at the BIO International Convention 2022
Caladrius Biosciences, Inc. announced that David J. Mazzo, Ph.D., President and Chief Executive Officer of Caladrius, will present a corporate overview at the BIO International Convention being held in-person at the San Diego Convention Center in San Diego, CA, from June 13-16, 2022.
June 8, 2022
·
1 min read
Press Releases
Artelo Biosciences Announces Proposed Underwritten Public Offering
September 4, 2025
·
4 min read
Press Releases
Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors
September 9, 2025
·
3 min read
Press Releases
Enveric Biosciences Relocates Corporate Headquarters to Cambridge, MA
September 3, 2025
·
4 min read
1 of 3,920
Next
